Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1CNS 1

Conditions

Stroke 1Neoplasms 1Meningioma 1Ischemic Stroke 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Thrombectomy × 1 year × Clear all
NCT07298096 2026-02-02

A Prospective Single Center, Single Arm, Single-institution Registry That Aims to Assess the Safety and Quality of Life Benefits of Computer-assisted Vacuum Thrombectomy (CAVT) in the Treatment of Cancer Patients With Intermediate Risk Pulmonary Embolism (PE)

M.D. Anderson Cancer Center

Phase NA Recruiting
25 enrolled
Tumor-Agnostic

Neoplasms

NCT06752096 2026-01-16

Robot-Assisted Neurovascular Intervention

Navigantis Inc.

Phase NA Recruiting
10 enrolled
CNS

Ischemic Stroke, Meningioma, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡